Tff Pharmaceuticals Stock Gross Profit
| TFFP Stock | USD 2.20 0.11 5.26% |
Tff Pharmaceuticals fundamentals help investors to digest information that contributes to Tff Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Tff Stock. The fundamental analysis module provides a way to measure Tff Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tff Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 231.4 K | 243 K | |
| Gross Profit Margin | 0.28 | 0.26 |
Tff | Gross Profit |
Tff Pharmaceuticals Company Gross Profit Analysis
Tff Pharmaceuticals' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Tff Pharmaceuticals Gross Profit | (21.21 M) |
Most of Tff Pharmaceuticals' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tff Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tff Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Tff Pharmaceuticals is extremely important. It helps to project a fair market value of Tff Stock properly, considering its historical fundamentals such as Gross Profit. Since Tff Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tff Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tff Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Tff Pharmaceuticals reported (21.21 Million) of gross profit. This is 100.95% lower than that of the Pharmaceuticals sector and 102.23% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.08% higher than that of the company.
Tff Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tff Pharmaceuticals' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tff Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tff Pharmaceuticals by comparing valuation metrics of similar companies.Tff Pharmaceuticals is currently under evaluation in gross profit category among related companies.
Tff Fundamentals
| Return On Equity | -1.31 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (46.96) % | ||||
| Current Valuation | 179.43 K | ||||
| Shares Outstanding | 3.1 M | ||||
| Shares Owned By Insiders | 2.80 % | ||||
| Shares Owned By Institutions | 12.21 % | ||||
| Number Of Shares Shorted | 69.73 K | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 13.22 X | ||||
| Revenue | 733.87 K | ||||
| Gross Profit | (21.21 M) | ||||
| EBITDA | (22.13 M) | ||||
| Net Income | (21.24 M) | ||||
| Cash And Equivalents | 13.15 M | ||||
| Cash Per Share | 0.51 X | ||||
| Total Debt | 115.25 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (16.04 M) | ||||
| Short Ratio | 1.23 X | ||||
| Earnings Per Share | (11.85) X | ||||
| Target Price | 24.5 | ||||
| Number Of Employees | 19 | ||||
| Beta | 1.29 | ||||
| Market Capitalization | 6.82 M | ||||
| Total Asset | 12.03 M | ||||
| Retained Earnings | (118.33 M) | ||||
| Working Capital | 5.16 M | ||||
| Net Asset | 12.03 M |
About Tff Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tff Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tff Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tff Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Tff Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Tff Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Tff Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Tff Pharmaceuticals Stock:Check out Tff Pharmaceuticals Piotroski F Score and Tff Pharmaceuticals Altman Z Score analysis. To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.Note that the Tff Pharmaceuticals information on this page should be used as a complementary analysis to other Tff Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Tff Stock analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Tff Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tff Pharmaceuticals. If investors know Tff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tff Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.85) | Revenue Per Share 0.409 | Quarterly Revenue Growth (0.63) | Return On Assets (0.76) | Return On Equity (1.31) |
The market value of Tff Pharmaceuticals is measured differently than its book value, which is the value of Tff that is recorded on the company's balance sheet. Investors also form their own opinion of Tff Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Tff Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tff Pharmaceuticals' market value can be influenced by many factors that don't directly affect Tff Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tff Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tff Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tff Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.